Abstract
The locomotor effects in mice of selective A1 and A2 adenosine agonists, antagonists and combinations of agonists were investigated using a computerized activity monitor. The A2-selective agonist 2-[(2-aminoethylamino)carbonylethylphenylethylamino[-5'-N- ethylcarboxamidoadenosine (APEC), an amine derivative of 2-(carboxyethylphenylethylamino)adenosine-5'-carboxamide, was a more potent locomotor depressant than its amide conjugates. The rank order of potency after i.p. injection for adenosine agonists was 5'-N-ethylcarboxamidoadenosine (NECA) (ED50, 5.8 nmol/kg) greater than APEC (ED50, 25 nmol/kg) greater than N6-cyclohexyladenosine (CHA) (ED50, 270 nmol/kg). An A1-selective, centrally acting, adenosine antagonist, 8-cyclopentyltheophylline (10 mg/kg), completely reversed the locomotor depressant effects of CHA (A1-selective) and NECA (nonselective) at doses of agonists as high as twice the ED50, and shifted the dose-response curves to the right, suggesting a primary involvement of A1 receptors. 8-cyclopentyltheophylline did not affect the depressant effects of APEC at the ED50, consistent with the A2-selectivity of APEC. The locomotor effects of APEC and CHA were completely reversed by theophylline, but not by the peripherally active 8-p-sulfophenyltheophylline, indicating central action of the adenosine agonists. The depressant effects of APEC, but not of NECA or CHA, were reversed significantly by an A2-selective adenosine receptor antagonist, 4-amino-8-chloro-1-phenyl-[1,2,4]triazol[4,3-a]quinoxaline. Low or subthreshold doses of CHA potentiated the depressant effects of APEC. A subthreshold dose of CHA did not alter the depressant effect of NECA, whereas a subthreshold dose of APEC increased the depressant effects of low doses of NECA. Thus, it appears that A1- and A2-selective adenosine agonists have separate central depressant effects, which can be potentiative.(ABSTRACT TRUNCATED AT 250 WORDS)
MeSH Terms
Adenosine/analogs & derivatives,antagonists & inhibitors,pharmacology
Adenosine-5'-(N-ethylcarboxamide)
Animals
Injections, Intraperitoneal
Locomotion/drug effects
Male
Mice
Phenethylamines/antagonists & inhibitors,pharmacology
Receptors, Purinergic/drug effects
Theophylline/analogs & derivatives,pharmacology
Vasodilator Agents/pharmacology
Chemicals
Phenethylamines
Receptors, Purinergic
Vasodilator Agents
2-((2-aminoethylamino)carbonylethylphenylethylamino)-5'-N-ethylcarboxamidoadenosine
8-cyclopentyl-1,3-dimethylxanthine
Adenosine-5'-(N-ethylcarboxamide)
Theophylline
Adenosine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Nikodijević O
Laboratory of Bioorganic Chemistry, National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Sarges R
Daly J W
Jacobson K A
References (34)
34 references, click to expand
-
In vivo behavioral assessment of central nervous system purinergic receptors.
Eur J Pharmacol. 1981 Dec 3;76(2-3):137-44
PMID: 6895875
-
Adenosine receptors and behavioral actions of methylxanthines.
Proc Natl Acad Sci U S A. 1981 May;78(5):3260-4
PMID: 6265942
-
Central effects of adenosine analogs on locomotor activity in mice and antagonism of caffeine.
Brain Res. 1983 Aug 8;272(2):392-5
PMID: 6616215
-
Interactions in the behavioral effects of methylxanthines and adenosine derivatives.
J Pharmacol Exp Ther. 1983 Oct;227(1):167-73
PMID: 6194284
-
Dissociation of the locomotor and hypotensive effects of adenosine analogues in the rat.
Neurosci Lett. 1984 Jul 27;48(2):139-44
PMID: 6483277
-
Adenosine as a neuromodulator.
Annu Rev Neurosci. 1985;8:103-24
PMID: 2858998
-
Automated measurement of multivariate locomotor behavior in rodents.
Neurobehav Toxicol Teratol. 1985 Jan-Feb;7(1):87-94
PMID: 3839052
-
Behavioural sensitivity to PIA in selectively bred mice is related to a number of A1 adenosine receptors but not to cyclic AMP accumulation in brain slices.
Eur J Pharmacol. 1985 Apr 23;111(1):133-6
PMID: 2990938
-
Stereoselective behavioral effects of N6-phenylisopropyl-adenosine and antagonism by caffeine.
Psychopharmacology (Berl). 1985;87(3):272-7
PMID: 3001804
-
Behavioral effects of caffeine, (-)N-((R)-1-methyl-2-phenylethyl)-adenosine (PIA), and their combination in the mouse.
Psychopharmacology (Berl). 1985;87(4):421-4
PMID: 3936100
-
The physiological role of adenosine in the central nervous system.
Int Rev Neurobiol. 1985;27:63-139
PMID: 2867982
-
Behavioral characteristics of centrally administered adenosine analogs.
Pharmacol Biochem Behav. 1986 Feb;24(2):263-70
PMID: 2419924
-
Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance.
Am J Physiol. 1983 May;244(5):H734-7
PMID: 6846564
-
Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
Mol Pharmacol. 1986 Apr;29(4):331-46
PMID: 3010074
-
Adenosine analogs mediating depressant effects on synaptic transmission in rat hippocampus: structure-activity relationships for the N6 subregion.
Naunyn Schmiedebergs Arch Pharmacol. 1986 Sep;334(1):77-85
PMID: 3024026
-
Behavioral effects of adenosine analogs in squirrel monkeys: relation to adenosine A2 receptors.
Psychopharmacology (Berl). 1986;90(3):419-21
PMID: 3097732
-
Inherent hyporesponsiveness to methylxanthine-induced behavioral changes associated with supersensitivity to 5'-N-ethylcarboxamidoadenosine (NECA).
Pharmacol Biochem Behav. 1986 Dec;25(6):1271-7
PMID: 3809230
-
Ca-antagonistic effects of adenosine in guinea pig atrial cells.
Am J Physiol. 1988 Oct;255(4 Pt 2):H872-8
PMID: 2845817
-
3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs.
Life Sci. 1988;43(21):1671-84
PMID: 3193854
-
Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity.
J Pharmacol Exp Ther. 1989 Mar;248(3):1078-83
PMID: 2539455
-
How does adenosine inhibit transmitter release?
Trends Pharmacol Sci. 1988 Apr;9(4):130-4
PMID: 2907698
-
NECA-induced hypomotility in mice: evidence for a predominantly central site of action.
Pharmacol Biochem Behav. 1989 Feb;32(2):487-90
PMID: 2727008
-
Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice.
Psychopharmacology (Berl). 1989;98(1):31-7
PMID: 2498959
-
CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
J Pharmacol Exp Ther. 1989 Oct;251(1):47-55
PMID: 2795469
-
Evidence for adenosine A2 receptor involvement in the hypomobility effects of adenosine analogues in mice.
Eur J Pharmacol. 1989 Sep 22;168(3):285-90
PMID: 2583238
-
Receptors that inhibit phosphoinositide breakdown.
Trends Pharmacol Sci. 1989 Mar;10(3):114-20
PMID: 2556822
-
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
J Pharmacol Exp Ther. 1989 Dec;251(3):888-93
PMID: 2600819
-
Characterization of the locomotor depression produced by an A2-selective adenosine agonist.
FEBS Lett. 1990 Feb 12;261(1):67-70
PMID: 2307237
-
Agonist derived molecular probes for A2 adenosine receptors.
J Mol Recognit. 1989 Dec;2(4):170-8
PMID: 2561548
-
4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
J Med Chem. 1990 Aug;33(8):2240-54
PMID: 2374150
-
Morphine and fentanyl anesthetic interactions with diazepam: relative antagonism in rats.
Anesth Analg. 1990 Sep;71(3):236-41
PMID: 2168134
-
Effects of caffeine and theophylline on activity of rats in relation to brain xanthine concentrations.
Proc Soc Exp Biol Med. 1972 Feb;139(2):582-6
PMID: 5059048
-
Synergy, additivism and antagonism in immunosuppression. A critical review.
Clin Exp Immunol. 1977 Apr;28(1):1-18
PMID: 324671
-
Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells.
J Neurochem. 1979 Nov;33(5):999-1005
PMID: 228008